These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34975319)

  • 41. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
    Zhao C; Wang B; Liu E; Zhang Z
    Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.
    Shang RZ; Qu SB; Wang DS
    World J Gastroenterol; 2016 Dec; 22(45):9933-9943. PubMed ID: 28018100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.
    Cheng Q; Ning D; Chen J; Li X; Chen XP; Jiang L
    Cancer Biol Ther; 2018 May; 19(5):381-390. PubMed ID: 29333942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The zinc finger protein GATA4 induces mesenchymal-to-epithelial transition and cellular senescence through the nuclear factor-κB pathway in hepatocellular carcinoma.
    Xiang Q; Zhou D; He X; Fan J; Tang J; Qiu Z; Zhang Y; Qiu J; Xu Y; Lai G
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2196-2205. PubMed ID: 30995348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection.
    Wang S; Ma H; Li X; Mo X; Zhang H; Yang L; Deng Y; Yan Y; Yang G; Liu X; Sun H
    Aging (Albany NY); 2020 Jan; 12(2):1171-1185. PubMed ID: 31977318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
    Zheng YL; Li L; Jia YX; Zhang BZ; Li JC; Zhu YH; Li MQ; He JZ; Zeng TT; Ban XJ; Yuan YF; Li Y; Guan XY
    Theranostics; 2019; 9(3):796-810. PubMed ID: 30809309
    [No Abstract]   [Full Text] [Related]  

  • 49. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Butein Inhibited In Vitro Hexokinase-2-Mediated Tumor Glycolysis in Hepatocellular Carcinoma by Blocking Epidermal Growth Factor Receptor (EGFR).
    Liao W; Liu J; Zhang D; Huang W; Chen R
    Med Sci Monit; 2018 May; 24():3283-3292. PubMed ID: 29777095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
    Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
    Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma.
    Liu Z; Ye Q; Wu L; Gao F; Xie H; Zhou L; Zheng S; Xu X
    Mol Carcinog; 2018 Nov; 57(11):1435-1444. PubMed ID: 29873415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
    Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
    Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
    Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
    J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
    Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
    Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
    [No Abstract]   [Full Text] [Related]  

  • 58. Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma.
    Zhang LF; Lou JT; Lu MH; Gao C; Zhao S; Li B; Liang S; Li Y; Li D; Liu MF
    EMBO J; 2015 Nov; 34(21):2671-85. PubMed ID: 26346275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
    Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
    [No Abstract]   [Full Text] [Related]  

  • 60. Androgen Receptor Stimulates Hexokinase 2 and Induces Glycolysis by PKA/CREB Signaling in Hepatocellular Carcinoma.
    Sun RF; Zhao CY; Chen S; Yu W; Zhou MM; Gao CR
    Dig Dis Sci; 2021 Mar; 66(3):802-813. PubMed ID: 32274668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.